Spectral Medical Inc. EDT.TO
Health Care · Health Care Equipment & Services · TSX · Canada
Spectral Medical Inc. is a late-stage theranostic company focused on therapeutic solutions for sepsis and septic shock. Its lead product, Toraymyxin (PMX), is a hemoperfusion device approved in Japan and Europe that removes endotoxin from the bloodstream, guided by the company's Endotoxin Activity Assay (EAA), the only FDA-cleared diagnostic for sepsis risk assessment.
Key ratios
FreeCashFlowOnSale TTM -3.98
FreeCashFlowOnSale 2025 -3.98
FreeCashFlowOnSale 2024 -3.87
FreeCashFlowOnSale 2023 -6.82
ReturnOnAssets TTM -1.22
ReturnOnAssets 2025 -1.22
ReturnOnAssets 2024 -1.43
ReturnOnAssets 2023 -0.81
Recent news
Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX
2026-06-25 · BioSpace
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
2026-06-09 · Spectral Medical